Will Brexit Actually Happen?

Following two posts on Brexit and British biotechnology, I would like to provide a perspective that turns everything on its head. It seems increasingly unlikely that Brexit will actually take place. The rationale for this argument has nothing to do with Britons having second thoughts, but is based on economic and legal arguments. Firstly, the […]



Brexit and British Biotech; A Second Look from ESOF

In the wake of my recent post on the potential impact of Brexit on British Biotechnology, I am fortunate to be at the European Science Open Forum (ESOF). The EuroScience Open Forum (ESOF) is a biennial, pan-European, general science conference dedicated to scientific research and innovation. It is similar in scope to the AAAS conference in […]



Drug Patent Expirations for Jul 21, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VALTREX (valacyclovir hydrochloride) Glaxosmithkline Patent number: 6,107,302 Expiration Date: Jul 19, 2016 VALTREX (valacyclovir hydrochloride) Glaxosmithkline Patent number: 5,879,706 Expiration Date: Jul 19, 2016 POMALYST (pomalidomide) […]



Brexit and British Biotech

I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom. I have been measuring global biotechnology for eight years and my objective data-driven metrics provide both a baseline to gauge future directions, and guidance for how to improve the sector’s performance. Eight years ago I […]



Drug Patent Expirations for Jul 14, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. CIALIS (tadalafil) Lilly Patent number: 6,140,329 Expiration Date: Jul 11, 2016 ZEGERID (omeprazole; sodium bicarbonate) Santarus Inc Patent number: 5,840,737 Expiration Date: Jul 15, 2016 ZEGERID […]



Drug Patent Expirations for Jul 7, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. CRESTOR (rosuvastatin calcium) Ipr Patent number: RE 37,314 Expiration Date: Jul 8, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information […]



Drug Patent Expirations for Jun 30, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SIGNIFOR LAR (pasireotide pamoate) Novartis Pharms Corp Patent number: 6,225,284 Expiration Date: Jun 28, 2016 SIGNIFOR (pasireotide diaspartate) Novartis Patent number: 6,225,284 Expiration Date: Jun 28, […]



Mainstreaming the Microbiome – Part 2

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In mid-April I noted the quickening pace of commercial investment in microbiome translational research and made what now seems like a  paltry prediction to the effect that: “the […]



Drug Patent Expirations for Jun 23, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. TUDORZA PRESSAIR (aclidinium bromide) Astrazeneca Pharms Patent number: 6,071,498 Expiration Date: Jun 21, 2016 TUDORZA PRESSAIR (aclidinium bromide) Astrazeneca Pharms Patent number: 5,840,279 Expiration Date: Jun […]



FDA Orange Book Archives From 1980 to Present

The Food and Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluations, is an authoritative list of patents covering branded drugs, and of generic equivalents. The Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA under the Federal Food, Drug, and Cosmetic Act. Each edition includes […]